Trichotillomania: Signs, Support and Treatment | AstroPharma

Detailed, evidence-informed guide to trichotillomania treatment: habit reversal, behavioral therapy, medication limits, when to seek care and supportive scalp care through 2026.

Trichotillomania: A Detailed Guide to Behavioral Treatment, Medication and Supportive Scalp Care

Educational notice: This article cannot diagnose trichotillomania from a photograph or description and it is not an individual prescription. Hair loss can also result from dermatologic, hormonal, infectious, traction-related or hereditary causes, so persistent patches or scalp symptoms should be assessed by a clinician.

Trichotillomania, also called hair-pulling disorder, involves recurrent pulling of hair from the scalp, brows, lashes or other body areas. It can lead to irregular areas of hair loss and significant distress or interference with school, work, relationships or daily life. Pulling may be focused and linked to tension or an urge, or more automatic during reading, screen time or boredom. It is not a moral failing or simply a lack of willpower.

Start with a non-judgmental, whole-person assessment

A useful plan first rules out other causes of hair loss, then explores when and where pulling happens, the sensations or thoughts that precede it, what happens afterward, and whether anxiety, depression, OCD, skin picking or other concerns are present. A dermatologist, mental-health clinician and behavioral therapist with BFRB experience may work together. The aim is understanding and practical support—not blame.

Behavioral treatment: the best-supported starting point

Recent evidence continues to place behavioral therapy involving habit reversal training (HRT) at the center of care. HRT is often delivered within cognitive behavioral therapy (CBT). It does not ask a person to rely on willpower alone; it turns the behavior into observable steps that can be changed. [1] [2] [3]

| Treatment component | What it involves | Purpose | | --- | --- | --- | | Awareness training | Tracking time, setting, activity, emotions, sensations and early hand movements. | Identifying risk moments before—not after—pulling occurs. | | Competing response | Practicing a safe action that cannot be performed at the same time as pulling, selected with the therapist. | Riding out an urge without pulling. | | Stimulus control | Making targeted changes to routines, tools, screen-time context, seating or access to hair. | Reducing exposure to high-risk cues and ease of pulling. | | Social support | Teaching a trusted person to offer calm, non-shaming prompts and encouragement. | Improving consistency while reducing isolation. | | Relapse prevention | Writing a plan for early warning signs, stressful days and skills review. | Treating a lapse as information for the plan, not as failure. |

Behavioral approaches that may be added by a specialist

CBT can help examine unhelpful beliefs such as “I cannot tolerate this urge” and build more workable responses. Acceptance and Commitment Therapy (ACT) helps people notice urges and difficult feelings without automatically acting on them, while choosing behavior linked to personal values. When emotional dysregulation is prominent, Dialectical Behavior Therapy (DBT) skills—mindfulness, distress tolerance and emotion regulation—may be useful additions. Comprehensive Behavioral treatment (ComB) maps sensory, motor, cognitive, emotional and environmental contributors, then tailors the plan to the individual pattern. These approaches are complementary rather than universal replacements for HRT. [1] [2] [3]

For children and adolescents, early behavioral treatment remains the main approach. Parents and caregivers can learn to ask about triggers and support the agreed skill without punishment, shame or constant hair-checking. A 2025 review found pediatric medication evidence variable and insufficient to make medication a first-line option. [2]

Medication: a clinician-led adjunct, not a replacement for behavioral care

No medication is specifically approved for trichotillomania. A prescriber may discuss medication when symptoms are severe, conditions such as anxiety or depression co-occur, behavioral care alone is insufficient, or medication is part of a combined plan. Potential benefit must be weighed against age, medical history, other medicines, pregnancy or breastfeeding and side effects. Do not start, stop or change a medicine or supplement for hair pulling without clinical advice. [1] [3]

| Option a clinician may discuss | Current evidence | Key safety point | | --- | --- | --- | | N-acetylcysteine (NAC) | A 2026 meta-analysis found support for NAC, but response is not guaranteed and pediatric findings remain mixed. | It is not a substitute for assessment; a clinician should review medical conditions, interactions and possible gastrointestinal effects. | | Clomipramine | Some studies suggest potential benefit in selected cases, but evidence is not sufficient for a universal recommendation. | Requires prescribing and monitoring, including review of anticholinergic and cardiac risks as appropriate. | | Olanzapine | Some studies and selected cases suggest possible benefit; it is not first-line. | Potential metabolic and neurologic adverse effects require specialist decision-making and follow-up. | | SSRIs | They do not show consistent benefit for hair pulling alone, but may be appropriate for co-occurring anxiety or depression after assessment. | Selection and monitoring should target the co-occurring condition and adverse effects. | | Clonazepam | The latest meta-analysis did not find consistent support for efficacy in trichotillomania. | It is not presented as a recommended option because of limited benefit plus sedation and dependence risks. |

Other treatments that appear only in small reports or early trials are not enough for a general recommendation. Medication should never delay access to HRT or replace relapse-prevention skills. [1] [4]

A plan usually begins with a measurable goal—such as fewer pulling episodes or more use of a competing response—rather than a promise of immediate change. Follow-up reviews triggers, tracking data and treatment effects, then adjusts skills during periods of sleep disruption, school demands or stress. Co-occurring anxiety, depression, OCD or other repetitive behaviors should be addressed in parallel.

The role of CurlyEllie Hair Lotion in supportive care

After professional advice when there is hair loss, inflammation or sensitivity, CurlyEllie Hair Lotion may be included in a supportive scalp-and-hair-care routine if it is appropriate for the individual and well tolerated. A consistent routine may support comfort and appearance between appointments. It is important to separate supportive cosmetic care from treatment for the disorder: the lotion does not stop hair-pulling urges, does not treat trichotillomania, and does not replace HRT, mental-health care, medical assessment or prescribed medicine. Stop use and seek clinical advice if irritation, itching, pain or rash develops.

Seek urgent help for thoughts of self-harm or severe hopelessness, for swallowing hair with abdominal pain, vomiting or other digestive symptoms, or for severe pain, bleeding, discharge or signs of scalp infection. Any rapid or unexplained hair loss also deserves timely clinical assessment, even when someone feels reluctant to talk about pulling.

Behavioral treatment involving habit reversal is the most evidence-supported starting point. Care is individualized around triggers, age and co-occurring conditions, with selected medications discussed and monitored by clinicians when appropriate. Support, medical evaluation and gentle scalp care can work together, but no single product or medication is right for everyone.

[1] Fisak B, Shorb C, Patel D, Ezcurra V. The efficacy of psychotherapeutic and pharmacological interventions for trichotillomania: A review and meta-analysis. *Journal of Psychiatric Research*. 2026. https://pubmed.ncbi.nlm.nih.gov/41812482/

[2] Sharifi S, et al. Treatment Strategies for Pediatric Trichotillomania: State-of-the-Art Review on Progress and Persistent Challenges. *Pediatric Dermatology*. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12854921/

[3] Mayo Clinic. Trichotillomania (hair-pulling disorder): Diagnosis and treatment. https://www.mayoclinic.org/diseases-conditions/trichotillomania/diagnosis-treatment/drc-20355193

[4] Association for Behavioral and Cognitive Therapies. Trichotillomania Fact Sheet. https://www.abct.org/fact-sheets/trichotillomania/